Leland Metheny, MD
Showing of 2 results
UH Seidman Cancer Center Leads $7.3 Million Multi-Site Trial of Relapse Prevention in ALL
Survival at one year post-stem cell transplant is 100% - Innovations in Cancer | Fall 2020
Intraosseous Co-Transplantation Shows Better Engraftment in Stem Cell Transplant
Results of study lead to first-of-its-kind Phase I clinical trial at UH Seidman Cancer Center - Innovations in Cancer | Spring 2017
Results are loading...